<DOC>
	<DOCNO>NCT00634322</DOCNO>
	<brief_summary>The purpose study demonstrate whether use glucarpidase facilitate administration next cycle chemotherapy schedule improves safety tolerability HDMTX give LV</brief_summary>
	<brief_title>High Dose Methotrexate With Leucovorin Rescue With Without Glucarpidase Osteosarcoma</brief_title>
	<detailed_description />
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>osteosarcoma eligible receive 2 sequential cycle HDMTXLV prior administration glucarpidase progression disease previous MTX treatment</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>osteosarcoma</keyword>
	<keyword>high dose methotrexate</keyword>
	<keyword>leucovorin</keyword>
</DOC>